Goldman Sachs analyst Alexander Duval downgrades STMicroelectronics (NYSE:STM) from Neutral to Sell.
BioVie To Present Data From NE3107 Phase 2 Open-Label Trial At Society Of Biological Psychiatry Annual Meeting
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver
